Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb 6;195(5):E187-E192.
doi: 10.1503/cmaj.221607.

Pharmacologic prevention of migraine

Velina Tzankova  1 , Werner J Becker  1 , Tommy L H Chan  2
Affiliations
Review

Pharmacologic prevention of migraine

Velina Tzankova et al. CMAJ. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: Werner Becker reports receiving consulting fees from AbbVie, Novartis, Lundbeck, Eli Lilly, Teva and McKesson, and honoraria for lectures, presentations, manuscript writing and educational events from AbbVie, Novartis, Weber and Weber, Lundbeck and Teva. Dr. Becker serves as a volunteer member on the board of Migraine Canada and on the board of the Pain Society of Alberta. In the past, he has served on the boards of the Canadian Headache Society and the American Headache Society. Tommy Lik Hang Chan reports receiving unrestricted education grants from AbbVie, Teva and Novartis; honoraria from AbbVie, Eli Lilly, Miravo and Novartis; and travel stipends for attending conferences and meetings from AbbVie. Dr. Chan is on the advisory board for AbbVie, Eli Lilly, Teva, Lundbeck, Miravo and Novartis. No other competing interests were declared.

References

    1. Tzankova V, Becker WJ, Chan TLH. Diagnosis and acute management of migraine. CMAJ 2023;195:E153–8. - PMC - PubMed
    1. Ailani J, Burch RC, Robbins MS; Board of Directors of the American Headache Society. The American Headache Society consensus statement: update on integrating new migraine treatments into clinical practice. Headache 2021;61:1021–39. - PubMed
    1. American Headache Society. The American Headache Society position statement on integrating new migraine treatments into clinical practice. Headache 2019; 59:1–18. - PubMed
    1. Hepp Z, Dodick DW, Varon SF, et al. . Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: a retrospective claims analysis. Cephalalgia 2017;37:470–85. - PMC - PubMed
    1. Hepp Z, Dodick DW, Varon SF, et al. . Adherence to oral migraine-preventive medications among patients with chronic migraine. Cephalalgia 2015;35:478–88. - PubMed

MeSH terms

Substances